Shabir Madhi to Streptococcal Vaccines
This is a "connection" page, showing publications Shabir Madhi has written about Streptococcal Vaccines.
Connection Strength
5,092
-
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus. N Engl J Med. 2023 Jul 20; 389(3):215-227.
Score: 0,842
-
Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines. Expert Rev Vaccines. 2018 07; 17(7):635-651.
Score: 0,595
-
Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development. PLoS One. 2016; 11(12):e0169101.
Score: 0,535
-
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. Lancet Infect Dis. 2016 08; 16(8):923-34.
Score: 0,511
-
Ethical considerations for designing GBS maternal vaccine efficacy trials in low-middle income countries. Vaccine. 2015 Nov 25; 33(47):6396-400.
Score: 0,486
-
Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013 Aug 28; 31 Suppl 4:D52-7.
Score: 0,424
-
Surface protein distribution in Group B Streptococcus isolates from South Africa and identifying vaccine targets through in silico analysis. Sci Rep. 2024 09 30; 14(1):22665.
Score: 0,229
-
Distributions of candidate vaccine Targets, virulence Factors, and resistance features of invasive group B Streptococcus using Whole-Genome Sequencing: A Multicenter, population-based surveillance study. Vaccine. 2024 Jun 11; 42(16):3564-3571.
Score: 0,222
-
Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions. Vaccine. 2019 08 14; 37(35):4877-4885.
Score: 0,159
-
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations. Vaccine. 2019 05 27; 37(24):3190-3198.
Score: 0,157
-
Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics. Vaccine. 2019 11 28; 37(50):7391-7393.
Score: 0,144
-
Prospects for preventing infant invasive GBS disease through maternal vaccination. Vaccine. 2017 08 16; 35(35 Pt A):4457-4460.
Score: 0,135
-
WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016. Vaccine. 2019 11 28; 37(50):7307-7314.
Score: 0,134
-
Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance Methodology. PLoS One. 2016; 11(4):e0152524.
Score: 0,127
-
Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1). Emerg Infect Dis. 2015 Apr; 21(4):638-45.
Score: 0,118
-
Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine. 2014 Apr 07; 32(17):1954-63.
Score: 0,110
-
Serocorrelates of protection against infant group B streptococcus disease. Lancet Infect Dis. 2019 05; 19(5):e162-e171.
Score: 0,039
-
Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates? Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S89-S99.
Score: 0,035
-
Challenges in reducing group B Streptococcus disease in African settings. Arch Dis Child. 2017 Jan; 102(1):72-77.
Score: 0,033
-
Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. Lancet Infect Dis. 2016 May; 16(5):546-555.
Score: 0,031
-
Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South Africa. J Med Microbiol. 2013 Feb; 62(Pt 2):249-253.
Score: 0,025